Medicamen Organics Ltd

Issue
Opens On Closes On
21-Jun-24 25-Jun-24
Money Payable On
Application Allotment
34.00 0.00

Minimum Application for shares in Nos : 4000 Further Multiples of : 4000

Lead Managers to the Issue
Project Cost (₹.Cr) 9.64 GYR Capital Advisors Pvt Ltd
Project Financed through Current Offer (₹.Cr) 10.54  
Post Issue Equity Share Capital (₹.Cr) 11.70
Issue Price (₹) 34.00
Projects

Funding of expenses proposed to be incurred towards products registration in the international markets

Plant updation and increase in production capacity

Funding working capital requirements of the company

General corporate purposes

Promoted By
Bal Kishan Gupta
Ashutosh Gupta
Listing At
NSE - SME
Registrar to the Issue
No Data Available
Initial public offer of upto 31,00,000 equity shares of face value of Rs. 10/- each ("Equity Shares") of Medicamen Organics Limited (the "Company" or "Medicamen" or "Issuer") at an issue price of Rs. 34 per equity share (including a share premium of Rs. 24 per equity share) for cash, aggregating up to Rs. 10.54 crores ("Public Issue") out of which 1,72,000 equity shares of face value of Rs. 10/- each at an issue price of Rs. 34 per equity share for cash, aggregating Rs. 0.58 crores will be reserved for subscription by the market maker to the issue (the "Market Maker Reservation Portion"). The public issue less market maker reservation portion i.e. issue of upto 29,28,000 equity shares of face value of Rs. 10/- each at an issue price of Rs. 34 per equity share for cash, aggregating up to Rs. 9.96 crores is hereinafter referred to as the "Net Issue". The public issue and net issue will constitute 26.49 % and 25.02 % respectively of the post-issue paid-up equity share capital of the company.